Learning objectives

After watching this webinar, participants will be able to:                                      

• understand the importance of risk stratification in cancer patients receiving antitumor therapies to prevent cardiotoxicity;
• present the ESC Guidelines on Cardio-Oncology strategy for stratifying the risk of cardiovascular toxicity in patients undergoing cancer treatment; and
• demonstrate how to apply these guidelines in daily clinical practice using real-world clinical cases.

Needs assessment and expected educational outcome

To harmonise strategies in risk stratification for high-risk HF patients across Europe who are also being treated for cancer and require closer monitoring.

Main topic:

• Cardio-oncology

Related topics:

• Cardiovascular toxicity risk stratification

For a complete overview on cardio-oncology, please visit the dedicated ESC Guidelines website.

For more focused information about this topic, please watch the following webinar on Multidisciplinary strategies for monitoring and managing cardiovascular toxicity in patients with cancer on February 18th, 2025.

Please find the dedicated page on this topic in the FOCUS February edition.

Session information

This webinar is designed for general practitioners, primary care doctors and general cardiologist but also cardiologists wishing to update their scientific knowledge on the topic.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).